Agentix Corp. (AGTX)
OTCMKTS · Delayed Price · Currency is USD
0.0337
-0.0153 (-31.22%)
At close: Nov 6, 2026
Agentix Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.35M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 1.24K | - | - |
| Aug 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Emmaus Life Sciences | 15.53M |
| International Stem Cell | 9.51M |
| Avenue Therapeutics | 1.40M |
| AXIM Biotechnologies | 92.90K |
| Enzolytics | 46.59K |
| Halberd | 6.94K |